Table I.
NCH participants | CCHMC participants | Total participants | Patientsb at NCH | Patientsb at CCHMC | |
---|---|---|---|---|---|
Adolescent Patients on hydroxyurea (n) | 18 | 11 | 29 | 34 | 33 |
Median age, in years (range) | 14 (12–18) | 16 (13–17) | 14 (12–18) | 14 (12–18) | 16 (12–18) |
Female (n) | 11 | 7 | 18 | 17 | 17 |
SCD genotype (n) | |||||
SS or Sβ0 | 17 | 9 | 26 | 31 | 29 |
Other (e.g., SC, Sβ+) | 1 | 2 | 3 | 3 | 4 |
Race | |||||
Black/African American | 13 | 11 | 24 | – | – |
African | 4 | 0 | 4 | ||
Black/African American and African | 1 | 0 | 1 | ||
Caregivers (n) | 18 | 11 | 29 | – | – |
Median age, in years (range) | 40 (34–68) | 40 (33–55)a | 40 (33–68)a | – | – |
Relationship to adolescent | |||||
Mother | 12 | 7 | 19 | – | – |
Father | 5 | 4 | 9 | ||
Grandmother | 1 | 0 | 1 | ||
Education level (n) | |||||
<12th grade | 3 | 1 | 4 | ||
High school diploma or General Education Diploma | 4 | 1 | 5 | ||
Some college, no degree | 4 | 3 | 7 | – | – |
Associates degree | 2 | 0 | 2 | ||
Bachelor’s degree | 3 | 3 | 6 | ||
Graduate or professional degree | 2 | 3 | 5 |
Two caregivers did not report their age.
Prescribed hydroxyurea and were 12–18 years of age at the beginning of enrollment.